Reddy B S, Rozati R, Reddy B V R, Raman N V V S S
Department of Reproductive Medicine, Bhagwan Mahavir Medical Research Centre, A.C. Guards, Hyderabad-500 004, Andhra Pradesh, India.
BJOG. 2006 May;113(5):515-20. doi: 10.1111/j.1471-0528.2006.00925.x.
To evaluate the possible association between phthalate esters (PEs) and the occurrence of endometriosis.
Case-control study.
Department of Reproductive Medicine, Bhagawan Mahavir Medical Research Centre, Maternal Health and Reproductive Institute and Department of Analytical R&D, Hetero Research Foundation, Hyderabad, Andhra Pradesh, India.
Blood samples were collected from 49 infertile women with endometriosis (study group); 38 age-matched women without endometriosis (control group I) but with infertility related to tubal defects, fibroids, polycystic ovaries, idiopathic infertility and pelvic inflammatory diseases diagnosed by laparoscopy and a further group of 21 age-matched women (control group II) with proven fertility and no evidence of endometriosis and other gynaecological disorders during laparoscopic sterilisation.
Concentrations of PEs were measured using gas chromatography.
Evaluation of PEs concentrations in women with endometriosis compared with women free from the disease.
Women with endometriosis showed significantly higher concentrations of di-n-butyl phthalate (DnBP), butyl benzyl phthalate (BBP), di-n-octyl phthalate (DnOP) and diethyl hexyl phthalate (DEHP) (mean 0.44 [SD 0.41]; 0.66 [SD 0.61]; 3.32 [SD 2.17]; 2.44 [SD 2.17] micrograms/ml) compared with control group I (mean 0.08 [SD 0.14]; 0.12 [SD 0.20]; 0; 0.50 [SD 0.80] micrograms/ml) and control group II (mean 0.15 [SD 0.21]; 0.11 [SD 0.22]; 0; 0.45 [SD 0.68] micrograms/ml). The correlation between the concentrations of PEs and different severity of endometriosis was strong and statistically significant at P < 0.05 for all four compounds (DnBP: r=+0.73, P < 0.0001; BBP: r=+0.78, P < 0.0001; DnOP: r=+0.57, P < 0.0001 and DEHP: r=+0.44, P < 0.0014).
This study suggests that PEs may have an aetiological association with endometriosis.
评估邻苯二甲酸酯(PEs)与子宫内膜异位症发生之间的可能关联。
病例对照研究。
印度安得拉邦海得拉巴市巴格万·马哈维尔医学研究中心生殖医学科、孕产妇健康与生殖研究所,以及赫特罗研究基金会分析研发部。
从49例患有子宫内膜异位症的不孕女性(研究组)中采集血样;38例年龄匹配但无子宫内膜异位症的女性(对照组I),她们因输卵管缺陷、子宫肌瘤、多囊卵巢、特发性不孕和盆腔炎导致不孕,且经腹腔镜检查确诊;另外还有21例年龄匹配的女性(对照组II),她们生育能力正常,且在腹腔镜绝育手术中未发现子宫内膜异位症及其他妇科疾病迹象。
采用气相色谱法测量PEs浓度。
比较患有子宫内膜异位症的女性与未患该病女性的PEs浓度。
与对照组I(均值0.08 [标准差0.14];0.12 [标准差0.20];0;0.50 [标准差0.80]微克/毫升)和对照组II(均值0.15 [标准差0.21];0.11 [标准差0.22];0;0.45 [标准差0.68]微克/毫升)相比,患有子宫内膜异位症的女性邻苯二甲酸二正丁酯(DnBP)、邻苯二甲酸丁苄酯(BBP)、邻苯二甲酸二正辛酯(DnOP)和邻苯二甲酸二(2-乙基己基)酯(DEHP)浓度显著更高(均值分别为0.44 [标准差0.41];0.66 [标准差0.61];3.32 [标准差2.17];2.44 [标准差2.17]微克/毫升)。对于所有四种化合物(DnBP:r = +0.73,P < 0.0001;BBP:r = +0.78,P < 0.0001;DnOP:r = +0.57,P < 0.0001;DEHP:r = +0.44,P < 0.0014),PEs浓度与子宫内膜异位症不同严重程度之间的相关性很强且具有统计学意义(P < 0.05)。
本研究表明PEs可能与子宫内膜异位症存在病因学关联。